Nodular hyperplasia of the prostate is the non-cancerous overgrowth of prostate tissue, commonly known as Benign Prostatic Hyperplasia (BPH). It forms small nodules that enlarge the gland and can cause urinary symptoms like weak flow or frequent urination.

Prostate cancer management depends on the stage and may include active surveillance, surgery, radiation therapy, hormone therapy, or targeted medications. Your doctor tailors treatment based on PSA levels, scans, age, and overall health for the best outcome.

Calutide 50 (bicalutamide) should not be taken as a substitute unless your doctor specifically prescribes it. It is used for prostate cancer treatment and cannot replace other medicines on your own. Always follow your doctor's advice before switching.

Frequent nighttime urination and an enlarged prostate are usually signs of BPH, not prostate cancer. A PSA of 1.8 is low, which makes cancer unlikely. Your doctor may also check for prostatitis or infection to confirm the exact cause.

Difficulty with erections is not a reliable sign of prostate cancer and is more often related to BPH, stress, blood flow issues, or hormonal changes. With a low PSA and your symptoms, cancer is unlikely, but follow-up with your doctor ensures proper evaluation and peace of mind.

Calutide 50 (bicalutamide) is used only for prostate cancer treatment, not for routine urinary symptoms or BPH. If your PSA is normal, it's usually not indicated, and urinary issues are likely due to BPH or other benign causes. Consult your doctor before using it.